Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Apr;17(2):161-6.
doi: 10.1007/BF02788534.

Serum beta 2-microglobulin in chronic diseases of the pancreas

R Pezzilli  1 , P Billi, M Fiocchi, E Beltrandi, O Cappelletti, G Sprovieri, M Miglioli
Affiliations

Serum beta 2-microglobulin in chronic diseases of the pancreas

R Pezzilli et al. Int J Pancreatol. 1995 Apr.

Abstract

Elevated serum concentrations of beta 2-Microglobulin (beta 2-MG) has been reported in a variety of chronic diseases and solid tumors. We determined serum beta 2-MG concentrations in 140 subjects divided into five groups: group 1, 34 patients with proven chronic pancreatitis, 8 of whom were studied during a painful relapse; group 2, 40 patients with pancreatic cancer staged according to the Cubilla-Fitzgerald classification; group 3, 40 healthy subjects; group 4, 10 patients with digestive nonpancreatic carcinomas; group 5, 16 patients with benign digestive nonpancreatic diseases. Serum soluble interleukin-2 receptor (sIL-2R) was also determined in all patients with pancreatic diseases as an index of immune system activation. In addition, serum CA 19-9 was assayed in patients of groups 2 and 4, and C-reactive protein (CRP) of groups 1 and 5. Renal function, evaluated by serum creatinine determination, was normal in all subjects studied. Patients with pancreatic cancer and those with chronic pancreatitis had serum concentrations of beta 2-MG significantly higher than those of healthy subjects (p < 0.001 and p < 0.005, respectively). Patients with stage I and stage III pancreatic cancer had similar serum levels of beta 2-MG, and these concentrations were significantly lower than those of patients with stage II tumors (p < 0.002 and p < 0.05, respectively). In chronic pancreatitis patients, those studied during painful relapse of the disease had serum concentrations of beta 2-MG similar to those studied during clinical remission.(ABSTRACT TRUNCATED AT 250 WORDS)

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Gastroenterology. 1988 Oct;95(4):1063-8 - PubMed
    1. J Clin Chem Clin Biochem. 1981 Jun;19(6):339-45 - PubMed
    1. J Exp Med. 1980 Aug 1;152(2 Pt 2):11s-17s - PubMed
    1. Digestion. 1994;55(4):268-73 - PubMed
    1. Transplantation. 1973 Mar;15(3):312-9 - PubMed

MeSH terms